Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
J Steroid Biochem Mol Biol. 2020 Jul;201:105698. doi: 10.1016/j.jsbmb.2020.105698. Epub 2020 May 11.
J Steroid Biochem Mol Biol. 2020.
PMID: 32404282